MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Eye, Ocular, Optometry, Ophthalmology, Vision Health Companies
Ophthotech (NASDAQ: OPHT)
Organization & Developments: Ophthotech
Parents
Ophthotech (NASDAQ: OPHT)
Children
2016: Is Ophthotech The Next Regeneron? - Ophthotech Corporation (NASDAQ:OPHT)
2016: Ophthotech (NASDAQ:OPHT) Spotlight, Biotech Forum Daily Digest: Biotech Tries To Break Through Upward Resistance Levels
2016: Ophthotech Eye Drug Fails Badly in Pivotal Test, Shares Crumble
2016: Revisiting The Investment Case On Ophthotech - Ophthotech Corporation (NASDAQ:OPHT)
2017: Ophthotech’s Final Try at Combo Eye Drug Comes up Short
Most advanced product candidate, is a PDGF-BB inhibitor with the potential to enhance visual outcomes in patients with wet AMD when used in combination with anti-VEGF therapy
Therapies for Wet Age-Related Macular Degeneration (AMD)
Jumps
*Key People: Ophthotech
Finance & Acquisitions: Ophthotech